Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Ms. Hilda Harris PiellSenior MD & Chief HR Officer | -5,75k | 1,75M | Verkauf | 304,63 | 27,70k | -17,20% |
| 2026-05-15 | Mr. Terrence A. DuffyChairman & CEO | -35,00k | 10,45M | Verkauf | 298,14 - 299,58 | 55,63k | -38,62% |
| 2026-03-26 | Mr. William R. ShepardIndependent Director | 1,47k | 437,10k | Kauf | 297,38 | 262,66k | 0,56% |
| 2026-03-17 | Mr. Jonathan L. MarcusSenior MD & General Counsel | -3,29k | 1,03M | Automatic Disposition | 313,37 | 7,19k | -31,39% |
| 2026-03-15 | Ms. Julie M. WinklerSenior MD & Chief Commercial Officer | -3,66k | 1,14M | Sale to Issuer | 311,40 | 30,11k | -10,83% |
| 2026-03-15 | Mr. Derek L. SammannSenior MD & Global Head of Commodities Markets | -3,63k | 1,13M | Sale to Issuer | 311,40 | 31,36k | -10,37% |
| 2026-03-15 | Mr. Kendal VromanChief Transformation Officer | -3,14k | 976,24k | Sale to Issuer | 311,40 | 18,85k | -14,26% |
| 2026-03-15 | Mr. Terrence A. DuffyChairman & CEO | -27,87k | 8,68M | Sale to Issuer | 311,40 | 90,63k | -23,52% |
| 2026-03-15 | Ms. Suzanne SpragueSenior MD, Group COO & Global Head of Clearing | -2,52k | 783,17k | Sale to Issuer | 311,40 | 13,84k | -15,38% |
| 2026-03-15 | Mr. Jonathan L. MarcusSenior MD & General Counsel | -2,64k | 821,47k | Sale to Issuer | 311,40 | 10,48k | -20,11% |
| 2026-03-15 | Ms. Hilda Harris PiellSenior MD & Chief HR Officer | -3,04k | 946,34k | Sale to Issuer | 311,40 | 33,46k | -8,33% |
| 2026-03-15 | Mr. Tim McCourtSenior MD & Global Head of Equities, FX and Alternative Products | -2,90k | 904,31k | Sale to Issuer | 311,40 | 12,11k | -19,34% |
| 2026-03-15 | Mr. Sunil CutinhoChief Information Officer | -3,66k | 1,14M | Sale to Issuer | 311,40 | 23,59k | -13,43% |
| 2026-03-15 | Mr. Jack TobinMD & CAO | -179,00 | 55,74k | Sale to Issuer | 311,40 | 25,41k | -0,70% |
| 2026-03-15 | Ms. Lynne FitzpatrickPresident & CFO | -2,52k | 783,17k | Sale to Issuer | 311,40 | 23,91k | -9,52% |
| 2026-03-11 | Mr. Jack TobinMD & CAO | -105,00 | 0,00 | Other Disposition | - | 24,98k | -0,42% |
| 2026-03-12 | Mr. Kendal VromanChief Transformation Officer | -5,16k | 1,59M | Verkauf | 309,00 | 14,91k | -25,71% |
| 2026-03-06 | Ms. Elizabeth Anne CookIndependent Director | -1.000,00 | 320,00k | Verkauf | 320,00 | 17,79k | -5,32% |
| 2026-02-23 | Mr. Bryan Thomas DurkinIndependent Director | -4,20k | 1,30M | Verkauf | 309,65 | 43,01k | -8,90% |
| 2026-02-20 | Mr. Martin J. GepsmanIndependent Director | -300,00 | 91,77k | Verkauf | 305,90 | 25,00k | -1,19% |
| 2026-02-06 | Mr. Dennis A. SuskindIndependent Director | -748,00 | 224,40k | Verkauf | 300,00 | 2,70k | -21,70% |
| 2025-12-30 | Mr. William R. ShepardIndependent Director | 262,27 | 73,01k | Kauf | 278,37 | 261,19k | 0,10% |
| 2025-12-31 | Mr. Terrence A. DuffyChairman & CEO | -10,21k | 2,79M | Sale to Issuer | 273,08 | 55,59k | -15,52% |
| 2025-12-11 | Mr. Terrence A. DuffyChairman & CEO | -25,00k | 6,74M | Verkauf | 269,10 - 270,05 | 65,80k | -27,53% |
| 2025-11-20 | Mr. Derek L. SammannSenior MD & Global Head of Commodities Markets | -7,20k | 1,98M | Verkauf | 275,65 - 275,74 | 26,73k | -21,22% |
| 2025-11-06 | Mr. Derek L. SammannSenior MD & Global Head of Commodities Markets | -2,30k | 0,00 | Other Disposition | - | 26,73k | -7,92% |
| 2025-11-07 | Ms. Hilda Harris PiellSenior MD & Chief HR Officer | -973,00 | 0,00 | Other Disposition | - | 29,42k | -3,20% |
| 2025-11-03 | Mr. Harold Eugene FordIndependent Director | -1.000,00 | 263,53k | Verkauf | 263,53 | 1,09k | -47,82% |
| 2025-09-25 | Mr. William R. ShepardIndependent Director | 274,04 | 72,67k | Kauf | 265,19 - 265,22 | 260,93k | 0,11% |
| 2025-09-18 | Mr. Jonathan L. MarcusSenior MD & General Counsel | -392,00 | 102,70k | Automatic Disposition | 262,00 | 7,85k | -4,76% |
| 2025-09-15 | Mr. Kendal VromanChief Transformation Officer | -1,30k | 335,77k | Sale to Issuer | 258,83 - 259,83 | 20,07k | -6,07% |
| 2025-09-15 | Mr. Jack TobinMD & CAO | -200,00 | 51,82k | Sale to Issuer | 258,83 - 259,83 | 25,09k | -0,79% |
| 2025-09-15 | Ms. Julie M. WinklerSenior MD & Chief Commercial Officer | -1,46k | 378,27k | Sale to Issuer | 258,83 - 259,83 | 25,51k | -5,41% |
| 2025-09-15 | Mr. Sunil CutinhoChief Information Officer | -1,50k | 387,59k | Sale to Issuer | 258,83 - 259,83 | 18,99k | -7,30% |
| 2025-09-16 | Mr. Michael G. DennisSenior Managing Director & Global Head of Fixed Income | -289,00 | 75,09k | Sale to Issuer | 259,83 | 8,68k | -3,22% |
| 2025-09-15 | Ms. Lynne FitzpatrickPresident & CFO | -1,02k | 263,87k | Sale to Issuer | 258,83 - 259,83 | 20,92k | -4,64% |
| 2025-09-15 | Ms. Suzanne SpragueSenior MD, Group COO & Global Head of Clearing | -964,00 | 249,84k | Sale to Issuer | 258,83 - 259,83 | 10,85k | -8,16% |
| 2025-09-16 | Mr. Tim McCourtSenior MD & Global Head of Equities, FX and Alternative Products | -379,00 | 98,48k | Verkauf | 259,83 | 9,51k | -3,83% |
| 2025-09-15 | Mr. Tim McCourtSenior MD & Global Head of Equities, FX and Alternative Products | -754,00 | 195,16k | Sale to Issuer | 258,83 | 9,51k | -7,35% |
| 2025-09-16 | Mr. Jonathan L. MarcusSenior MD & General Counsel | -376,00 | 97,37k | Automatic Disposition | 258,96 | 8,24k | -4,36% |
| 2025-09-15 | Mr. Jonathan L. MarcusSenior MD & General Counsel | -553,00 | 143,43k | Sale to Issuer | 258,83 - 259,83 | 8,24k | -6,29% |
| 2025-09-15 | Mr. Derek L. SammannSenior MD & Global Head of Commodities Markets | -1,48k | 382,93k | Sale to Issuer | 258,83 - 259,83 | 33,93k | -4,17% |
| 2025-09-15 | Ms. Hilda Harris PiellSenior MD & Chief HR Officer | -1,28k | 331,11k | Sale to Issuer | 258,83 - 259,83 | 30,39k | -4,04% |
| 2025-08-26 | Mr. Sunil CutinhoChief Information Officer | -11,90k | 3,23M | Verkauf | 270,85 - 272,10 | 17,44k | -40,55% |
| 2025-06-25 | Mr. William R. ShepardIndependent Director | 267,39 | 72,34k | Kauf | 270,53 | 260,65k | 0,10% |
| 2025-06-10 | Mr. Charles Peter CareyIndependent Director | -500,00 | 132,68k | Verkauf | 265,35 - 265,36 | 5,09k | -8,95% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
